Release Date: 29/07/13 17:47 Summary: Quarterly Activities Report and Cash Flows Price Sensitive: Yes Download Document 807.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%